Registration Number
2121U010247, Article
popup.category
Текст
Title
Feasibility of cystatin c determination for early diagnosis of kidney damage in patients with type 2 diabetes combined with nonalcoholic fatty liver disease and obesity exposed to COVID-19 infection in the past (AI translated)
popup.author
Kateryna V. Sabovchyk
Yelyzaveta S. Sirchak
Vasyl V. Stryzhak
Kateryna V. Sabovchyk
Yelyzaveta S. Sirchak
Vasyl V. Stryzhak
popup.publication
01-01-2021
popup.source_user
Ужгородський національний університет
popup.source
https://dspace.uzhnu.edu.ua/jspui/handle/lib/74165
popup.publisher
Wiadomosci Lekarskie
Description
The aim: To examine the diagnostic possibilities of determining the level of cystatin C in the blood serum in order to ascertain the functional status of the kidneys in patients with type 2 diabetes (those who recovered from COVID-19 infection) depending on the presence or absence of non-alcoholic fatty liver disease (further – NAFLD) and malnutrition.
Materials and methods: We investigated 18 patients with type 2 DM, who were included in the first group of the patients examined; group 2 consisted of 20 patients with type 2 DM and non-alcoholic fatty liver disease (NAFLD), namely with non-alcoholic steatohepatitis; and group 3 of the patients examined consisted of 30 patients with type 2 DM and obesity.
popup.nrat_date
2026-06-13
